We would like to inform you that the new GDPR comes into effect on 25 May 2018, and organizations have until this date to implement changes to comply with the new legislation. The GDPR will significantly change EU data protection law, strengthening individual’s rights, extending territorial scope and increasing compliance obligations.
Due to changes in data protection regulation, Insud Pharma has updated and internally defined appropriate procedures for the management of processing of personal data in order to comply with the new requirements of the GDPR.
We hope you have found our communications informative, and we thank you for commitment with Insud Pharma and for your attention to this. If you have any questions regarding data protection, please email: email@example.com
We are working to transform health and you can be a part of this change.
Would you like to join our Group?
We are a global organisation with a clear project and a history of innovation and business excellence spanning more than 40 years.
Discover the opportunities offered by our organisation and our pharmaceutical companies:
Chemo: our industrial business that sells raw materials and pharmaceutical products to other pharmaceutical companies.
Exeltis: our brand division that markets drugs to the medical and pharmaceutical community.
mAbxience: a company that develops, produces and sells biosimilars.
We are now more than 6,000 professionals and we are still growing. Check out our job opportunities and apply to join our team!
If you would like to find out more about us, go to our websites.
| | |